Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Announce

SynbiCITE and UK Innovation & Science Seed Fund announce judge for Bio-start competition

27th September 2016

Sciad Newswire / SynbiCITE and UK Innovation & Science Seed Fund today announce that Dr David Lawrence, Non-executive…
Andrew Muir

A Discussion with Dr Andrew Muir Midven Director

23rd September 2016

Andrew Muir, PhD, is a director at Midven, and leads the UK Innovation & Science Seed Fund team.
Crispr cabbage

The heat is on for CRISPR cabbage

22nd September 2016

CRISPR-Cas9 is a precise and targeted technique for genome editing that allows even a single nucleotide change.
Oliver Sexton

A Discussion with UK Innovation & Science Seed Fund’s Oliver Sexton

1st September 2016

Oliver Sexton, MSc, is Midven’s investment director and manager of UK Innovation & Science Seed Fund’s engineering biology investments…
Podium

Engineering a winner: UK Innovation & Science Seed Fund & SynbiCITE create £200k competition

18th August 2016

Midven’s UK Innovation & Science Seed Fund, along with SynbiCITE, a pioneering Innovation and Knowledge Centre (IKC), have announced the launch of Bio-start.
Bio Start Competition

SynbiCITE And UK Innovation & Science Seed Fund Announce New £200k Competition For Engineering Biology

11th August 2016

Today marks the launch of Bio-start, an annual competition designed to bolster UK companies aiming to solve significant global problems through engineering biology.
Medication

Nine Key Steps To Fight Antibiotic Resistance

8th August 2016

In May 2016, the publication of Lord Jim O’Neill’s global Review on Antimicrobial Resistance (AMR) was the culmination of two years’ work.

Mark White

Mark White Joins Investor Panel at Innovate2016: The Global Spotlight on UK Innovation

27th July 2016

UKI2S Investment Director Mark White will speak on the Innovate UK’s investor panel “How to Pitch and Win” panel.
Lab work

Building A Synthetic Genome

22nd July 2016

Following the completion of the sequencing of the entire human genome in 2003, dubbed ‘Human Genome-read’, a team of over 20 scientists…
Synthetic bacterial cell

Researchers Build Synthetic Bacterial Cell With Just 473 Genes

11th July 2016

Following the creation of the world’s first synthetic cell, Mycoplasma mycoides JCVI-syn1.0 in 2010, researchers at the J Craig Venter Institute and Synthetic Genomics…
Geology Map IGS

Semantically-Driven Software Reduces Risk In Mineral Prospecting

1st July 2016

Mineral resources are vital to a growing and increasingly urbanized global population.

Microphone

Upcoming Investor Panels: Tech Invest (22 June) & Venturefest 2016 (29 June)

14th June 2016

On 29 June, Dr Andrew Muir, UK Innovation & Science Seed Fund’s Investment Director & Fund Principal, will speak at the 18th Venturefest 2016 event in Oxford.
Taking notes

Is Crowdfunding The Death Of VC?

3rd June 2016

Weight loss drug developer Symmetry Therapeutics has done it. Anti-infectives company ANTABIO has done it. Stem cell specialist Axol has done it.
Podium

Desktop Genetics Winner of the 2016 Start-up Battle at Labiotech Refresh Conference

25th May 2016

The winner of the Start-up Battle, a pitching competition taking place at Labiotech’s conference Refresh in Berlin on 24th May 2016,
silicon valley

Silicon Valley Series 3 Is Out And We’re A Big Fan

20th May 2016

Prepare for your next financing round or growth phase by catching up with the box sets of series 1 and 2 which chart the journey of a US VC-backed tech company.
Mirico

Harwell: ‘Brilliance every day’

12th May 2016

We are funding Mirico, an innovative spinout from the Rutherford Appleton Laboratory that is focused on developing state-of-the-art laser spectroscopy instrumentation.
technology

UK Innovation & Science Seed Fund Backs New STFC Spin Out MIRICO

11th May 2016

Spin out from UK publicly-funded research develops novel laser spectroscopy for environmental, medical diagnosis and industrial process monitoring.
Contego

Contego Selected For The FinTech50 2016

8th April 2016

Contego, a UK software company providing cloud-based identity verification and fraud solutions, has been selected as  one of the 2016 FinTech50.
Laptop

Synthace Partners With Microsoft To Bring Antha To Azure

6th April 2016

Synthace Ltd., a London based technology company developing Antha, a high level language and operating system for working with biology…
City-Cars-Road-Traffic

Strategic Plans For Engineering Biology In The UK

15th March 2016

The Minister for Life Sciences George Freeman MP has launched the UK Engineering Biology Strategic Plan 2016.
Orb of light

Light From The Sea – A Glowing Use For Engineering Biology

4th March 2016

Imagine a city lit by cool to touch, wireless, low carbon lighting. Glowee, a start-up based in Paris, France, is using engineering biology to create bioluminescence-based lighting in any shape.

Quethera gene therapy

Gene Therapy Company Quethera Obtains Grant From Wellcome Trust Pathfinder Award Scheme

4th March 2016

Quethera Ltd, a privately funded gene therapy company based at the Babraham Research Campus in Cambridge, has obtained a grant from the Wellcome Trust Pathfinder Award Scheme.
Crescendo

Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property

3rd February 2016

Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics, today announced the appointment of Dr Barbara Fleck as Head of Intellectual Property.
Adrian Black CEO Contego

Contego Announces Selection Into Accenture’s Innovation Lab

11th January 2016

January 7th, 2016 — Contego announces today that it is part of the Accenture FinTech Innovation Lab London, tipped to be the best one yet.
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.